Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.36 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.36 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.32 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.32 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8005421 | 0.84 | — | — | |
| SCHEMBL1357038 | 0.79 | — | — | |
| SCHEMBL8978426 | 0.79 | CYP3A4 (0.40) | CYP3A4ADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL7640731 | 0.77 | CYP3A4 (0.39) | CYP3A4ADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL3360879 | 0.76 | CYP3A4 (0.42) | CYP3A4ADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL9349496 | 0.75 | GGPS1 (0.47) | CA1CA2LPAR3LPAR1LPAR2 | |
| SCHEMBL3290589 | 0.74 | TSHR (0.41) | CYP3A4ADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL4980904 | 0.74 | TSHR (0.42) | CYP3A4ADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL2138838 | 0.73 | ADRB2 (0.43) | CYP3A4ADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL3177179 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103739747-A | Rare earth catalyst composition and 3,4-polyisoprene used for isoprene compound | CHANGCHUN APPLIED CHEMISTRY | 2014-04-23 | — | — | CN | claimed |
| CN-103724378-A | Isoprene-butadiene bipolymer and preparation method thereof | CHANGCHUN APPLIED CHEMISTRY | 2014-04-16 | — | — | CN | claimed |
| CN-107828005-A | A kind of method for synthesizing butadiene-isoprene homopolymer and copolymer | 青岛瑞林材料科技有限公司 | 2018-03-23 | — | — | CN | disclosed |
| CN-107722179-A | A kind of preparation method of butadiene-isoprene homopolymer and copolymer | 青岛瑞林材料科技有限公司 | 2018-02-23 | — | — | CN | disclosed |
| US-9670232-B2 | Molecular precursor compounds for zinc-group 13 mixed oxide materials | TRANSTRON SOLUTIONS LLC (US) | 2017-06-06 | — | — | US | disclosed |
| CN-103724378-B | Isoprene-butadiene bipolymer and preparation method thereof | 中国科学院长春应用化学研究所 | 2017-04-19 | — | — | CN | disclosed |
| EP-3102541-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR INDIUM GALLIUM ZINC OXIDE MATERIALS | TRANSTRON SOLUTIONS LLC (US) | 2016-12-14 | — | — | EP | disclosed |
| US-9455142-B2 | Molecular precursor compounds for ABIGZO zinc-group 13 mixed oxide materials | TRANSTRON SOLUTIONS LLC (US) | 2016-09-27 | — | — | US | disclosed |
| US-9404002-B2 | Molecular precursor compounds for indium gallium zinc oxide materials | TRANSTRON SOLUTIONS LLC (US) | 2016-08-02 | — | — | US | disclosed |
| CN-103739747-B | Rare earth catalyst combination and the 3,4-for isoprene compounds thereof are polymerized | CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY CHINESE ACADEMY OF SCIENCES (CN) | 2016-06-01 | — | — | CN | disclosed |
| US-20150221772-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR ABIZO ZINC-GROUP 13 MIXED OXIDE MATERIALS | PRECURSOR ENERGETICS, INC. (US) | 2015-08-06 | — | — | US | disclosed |
| US-5064818-A | PESTICIDAL PYRIMIDINYL (THIONO) (THIO)-PHOSPHORIC (PHOSPHONIC)ACID (AMIDE) ESTERS | BAYER AKTIENGESELLSCHAFT (DE) | 1991-11-12 | — | — | US | disclosed |
| EP-0395968-A1 | (Thiono) (thio)pyrimidyl-phosphonyl (phosphonic) ester (amid) | BAYER AG (DE) | 1990-11-07 | — | — | EP | disclosed |
| EP-0213377-B1 | PHOSPHORIC (PHOSPHONIC) ACID ESTERS | BAYER AG (DE) | 1989-02-15 | — | — | EP | disclosed |
| EP-0167894-B1 | PHOSPHORIC-ACID ESTERS | BAYER AG (DE) | 1988-09-14 | — | — | EP | disclosed |
| US-4665061-A | Certain (O-pyrid-2-yl)-5-trifluormethyl phosphoric, thiophosphoric, dithiophosphoric, phosphoramidic, thiophosphoramidic esters having insecticidal or nematocidal properties | BAYER AKTIENGESELLSCHAFT (DE) | 1987-05-12 | — | — | US | disclosed |
| EP-0213377-A1 | Phosphoric (phosphonic) acid esters | BAYER AG (DE) | 1987-03-11 | — | — | EP | disclosed |
| EP-0173857-A1 | Fungicidal agent based on phosphoryloximinoacetamide | BAYER AG (DE) | 1986-03-12 | — | — | EP | disclosed |
| EP-0132676-A2 | Phosphoric or phosphonic acid esters | BAYER AG (DE) | 1985-02-13 | — | — | EP | disclosed |
| EP-0100476-A2 | Phosphoric-acid esters, process for their preparation and their use as pesticides | BAYER AG (DE) | 1984-02-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150221772-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR ABIZO ZINC-GROUP 13 MIXED OXIDE MATERIALS | IKZF3, ZRANB2, ZFR | CYP3A4 470/4885ADRB2 2300/4885ADRB1 3289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.